Mass Tort brief
Catheter Verdicts, PFAS Settlements, and Algorithmic Injury Claims
Key developments across major mass tort proceedings, including medical device verdicts, corporate PFAS settlements, and digital safety MDLs.
Mass Tort
A $590M North Carolina settlement forces chemical makers to fund municipal water filtration — shifting long-term PFAS clean-up costs directly onto manufacturers.
BackgroundPer- and polyfluoroalkyl substances (PFAS) are long-lasting industrial chemicals that have triggered thousands of municipal water contamination suits nationwide. Under corporate separation agreements, Chemours, DuPont, and Corteva share legacy liabilities arising from historical manufacturing operations.
- Local public entities will receive $380 million from the agreement, including $95 million allocated specifically for Brunswick County water treatment infrastructure.
- Chemours will pay 50% of the total settlement over 15 years, with DuPont and Corteva splitting the remaining funding obligations.
- The settlement resolves environmental contamination claims stemming from fluorochemical production at the Fayetteville Works chemical plant.
Mass Tort
Consolidating Roblox suits into an MDL bypasses individual arbitration clauses — forcing public court disclosure over platform design and child safety practices.
BackgroundMultidistrict litigation consolidates parallel federal lawsuits before a single judge to streamline discovery and pretrial motions across complex product liability claims. Tech platforms increasingly face litigation alleging algorithmic design features fail to protect underage users from harm.
- Plaintiffs allege platform architecture and weak age verification enabled adult predators to systematically target and groom underage users.
- State attorneys general from Texas, Tennessee, Kentucky, and Louisiana are pursuing separate enforcement actions alleging similar child safety failures.
- The consolidation panel rejected compulsory individual arbitration defenses, ensuring proceedings will unfold in open public court.
Mass Tort
A $40M bellwether verdict against Bard sets a steep valuation benchmark for 4,000 catheter injury claims — pressuring Becton Dickinson toward a global settlement.
BackgroundMultidistrict litigation consolidates thousands of individual product liability suits before a single federal judge to streamline pretrial discovery. Bellwether trials serve as critical test cases that guide settlement valuations for remaining claims across the litigation.
- Plaintiff Kimberly Divelbliss suffered severe internal injuries after her implanted catheter fractured, causing plastic fragments to migrate into her heart.
- Nearly 4,000 product liability lawsuits alleging catheter fracturing and infection risks are currently consolidated in federal MDL No. 3081 in Arizona.
- The $40 million award follows an earlier bellwether trial that ended in a hung jury, with additional test cases scheduled for late 2026.
Mass Tort
Mass Tort
Mass Tort
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
